Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fatty Acid Research Institute (FARI) is a non-profit research organization dedicated to discovering and publishing health evidence for fatty acids. Founded in 2020 by Dr. William S. Harris, a leading expert in omega-3 research, the institute focuses on the physiological roles of long-chain fatty acids in human health. FARI conducts original clinical research and meta-analyses to better understand how fatty acid levels, particularly the Omega-3 Index, correlate with disease risk. Their work spans multiple therapeutic areas, including cardiovascular health, cognitive function, and maternal-fetal outcomes. By collaborating with academic institutions and clinical researchers globally, FARI aims to provide the scientific foundation for nutritional recommendations and public health policies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fatty Acid Research Institute.